Suchergebnisse - "Lapresa, Mariateresa"

PubPharm (11)

1

A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy : Effectiveness and Safety

enthalten in: Cancers | 2023

von Mantiero, M. | Bini, M. | Polignano, M. | +11

2

Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer : a retrospective cohort study and systematic literature review

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Caruso, G. | Bruni, S. | Lapresa, M. | +13

3

Myeloid neoplasms post PARP inhibitors for ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Caruso, G. | Gigli, F. | Parma, G. | +4

4

Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer : lessons learned and future directions

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Caruso, G. | Tomao, F. | Parma, G. | +5

CommentIn: Int J Gynecol Cancer. 2023 Apr 3;33(4):444-445. - PMID 36958753

5

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3) : a multicentre, open-label, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2023

von Pignata, S. | Scambia, G. | Schettino, C. | +128

CommentIn: Lancet Oncol. 2023 Mar;24(3):201-203. - PMID 37052963

6

Knowledge and attitudes towards clinical trials among women with ovarian cancer : results of the ACTO study

enthalten in: Journal of ovarian research | 2022

von Mosconi, P. | Roberto, A. | Cerana, N. | +32

7

Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer

enthalten in: Gynecologic oncology | 2022

von Colombo, N. | Tomao, F. | Benedetti Panici, P. | +18

8

Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab : secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Di Liello, R. | Arenare, L. | Raspagliesi, F. | +32

9

Neoadjuvant chemotherapy in cervical cancer : an update

enthalten in: Expert review of anticancer therapy | 2015

von Lapresa, M. | Parma, G. | Portuesi, R. | +1

10

Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen : results of a multicenter retrospective Italian study

enthalten in: Gynecologic oncology | 2005

von Gadducci, A. | Sartori, E. | Landoni, F. | +7